Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea
E. Nena, P. Steiropoulos, N. Papanas, O. Hatzizisi, G. Kyriazis, M. Antoniadou, E. Serasli, S. Papoti, V. Tsara, E. Maltezos, D. Bouros (Alexandroupolis, Thessaloniki, Greece)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Nena, P. Steiropoulos, N. Papanas, O. Hatzizisi, G. Kyriazis, M. Antoniadou, E. Serasli, S. Papoti, V. Tsara, E. Maltezos, D. Bouros (Alexandroupolis, Thessaloniki, Greece). Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea. Eur Respir J 2010; 36: Suppl. 54, 2249
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Gender difference on polysomnographic parameters of severely obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apneaSource: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? Source: Eur Respir J 2012; 39: 1547-1549 Year: 2012